Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > Articles online first > The Journal of Cardiovascular Surgery 2017 Jun 19

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints
Cite this article as

THE JOURNAL OF CARDIOVASCULAR SURGERY

A Journal on Cardiac, Vascular and Thoracic Surgery


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,179


eTOC

 

The Journal of Cardiovascular Surgery 2017 Jun 19

DOI: 10.23736/S0021-9509.17.10069-8

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Endovascular treatment of mycotic aortic aneurysms: a paradigm shift

Karl SÖRELIUS , Kevin MANI, Martin BJÖRCK, Anders WANHAINEN

Department of Surgical Sciences, Section of Vascular Surgery, Uppsala, Sweden


PDF  


Treatment of mycotic aortic aneurysms (MAA) composes a particularly difficult challenge. Open repair (OR) has been considered the gold standard, despite lack of evidence supporting its superiority compared with the emerging alternative endovascular aortic repair (EVAR). This review discusses the pros and cons of EVAR for MAAs by dissecting the three largest publications on MAAs, and concludes that there has been a paradigm shift in treatment of MAAs for the benefit of EVAR.

top of page

Publication History

Cite this article as

Sörelius K, Mani K, Björck M, Wanhainen A. Endovascular treatment of mycotic aortic aneurysms: a paradigm shift. J Cardiovasc Surg 2017 Jun 19. DOI: 10.23736/S0021-9509.17.10069-8

Corresponding author e-mail

karlsorelius@hotmail.com